Killian Meara

Positive topline results have been announced from a phase 3 trial evaluating the efficacy and safety of cebranopadol for the treatment of moderate

A discussion with Natalie DiPietro Mager, PharmD, PhD, professor of pharmacy practice at Ohio Northern University.

The prevalence of diabetes in the United States continues to grow and research estimates that 54.9 million Americans will have the condition by 2030.

Over 2 million women aged between 15 and 44 years in the United States live in a maternity care desert, an area with little to no obstetric services or providers.

A discussion with Natalie DiPietro Mager, PharmD, PhD, on how community pharmacists can improve access to contraceptive services.

Positive results from an intranasal human abuse potential study evaluating the intranasal pharmacokinetics and abuse potential of cebranopadol compared

Over 2 million women between the ages of 15 and 44 years in the United States live in an area without obstetric services or providers.

Nearly half of all patients with type 2 diabetes (T2D) were found to be deficient in multiple micronutrients, according to new data published in the

In a recent commentary published in the Journal of the American Pharmacists Association, Jennifer Bacci, PharmD, MPH, and her colleagues said that

The decision makes the selective NaV1.8 pain signal inhibitor the first new class of medicine to treat acute pain in over 20 years.